{"id":568,"date":"2026-03-12T17:26:16","date_gmt":"2026-03-12T16:26:16","guid":{"rendered":"https:\/\/biotechlerncenter.iph-multisite.berta-bewegt.ch\/?page_id=568"},"modified":"2026-03-13T16:49:38","modified_gmt":"2026-03-13T15:49:38","slug":"5-rationnement-des-medicaments-une-decision-epineuse","status":"publish","type":"page","link":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/hepatite-lorsque-le-foie-souffre-dune-inflammation\/5-rationnement-des-medicaments-une-decision-epineuse\/","title":{"rendered":"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse"},"content":{"rendered":"\n<p>Pendant de nombreuses ann\u00e9es, le traitement standard de l\u2019h\u00e9patite C \u00e9tait constitu\u00e9 d\u2019interf\u00e9ron et de ribavirine. Pour les patients, ce traitement est extr\u00eamement \u00e9prouvant: maux de t\u00eates permanents, fi\u00e8vre, faiblesse, perte d\u2019app\u00e9tit. Seul l\u2019espoir de gu\u00e9rison les aide \u00e0 supporter ce calvaire. Cependant, de nombreux patients ne gu\u00e9rissent pas, les premiers traitements n\u2019avaient un taux de gu\u00e9rison que d\u2019environ 20%.<br>Depuis quelques ann\u00e9es, il existe en Suisse de nouveaux m\u00e9dicaments qui non seulement augmentent \u00e9norm\u00e9ment le taux de gu\u00e9rison (actuellement entre 90 et 100%), mais n\u2019ont en outre presque plus d\u2019effets secondaires.<br>Le probl\u00e8me: les co\u00fbts. Les nouveaux m\u00e9dicaments sont cens\u00e9s gu\u00e9rir des milliers de patients, mais ils sont chers. Si chers que les autorit\u00e9s sanitaires (Office f\u00e9d\u00e9ral de la sant\u00e9 publique) ont d\u00e9cid\u00e9 un rationnement: les caisses-maladie ne sont oblig\u00e9es de prendre les co\u00fbts en charge que chez les patients dont le foie est d\u00e9j\u00e0 nettement atteint de fibrose ou qui souffrent de complications. D\u2019autres pays comme les \u00c9tats-Unis ou la Grande-Bretagne ont aussi introduit de telles restrictions. Ceci a d\u00e9clench\u00e9 un vif d\u00e9bat entre m\u00e9decins, patients, industrie et autorit\u00e9s. L\u2019espoir est que les prix baissent lorsque d\u2019autres m\u00e9dicaments arriveront sur le march\u00e9.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg\" alt=\"\" class=\"wp-image-4621\"\/><figcaption>Grafik 4: Wie Medikamente gegen Hepatitis C wirken.<br>Graphique 4: Mode d\u2019action des m\u00e9dicaments contre l\u2019h\u00e9patite C.<br>\u00a9 vfa<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Pendant de nombreuses ann\u00e9es, le traitement standard de l\u2019h\u00e9patite C \u00e9tait constitu\u00e9 d\u2019interf\u00e9ron et de ribavirine. Pour les patients, ce traitement est extr\u00eamement \u00e9prouvant: maux de t\u00eates permanents, fi\u00e8vre, faiblesse, perte d\u2019app\u00e9tit. Seul l\u2019espoir de gu\u00e9rison les aide \u00e0 supporter ce calvaire. Cependant, de nombreux patients ne gu\u00e9rissent pas, les premiers traitements n\u2019avaient un taux [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":548,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"page-templates\/unterthema.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-568","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse - biotechlerncenter<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse\" \/>\n<meta property=\"og:description\" content=\"Pendant de nombreuses ann\u00e9es, le traitement standard de l\u2019h\u00e9patite C \u00e9tait constitu\u00e9 d\u2019interf\u00e9ron et de ribavirine. Pour les patients, ce traitement est extr\u00eamement \u00e9prouvant: maux de t\u00eates permanents, fi\u00e8vre, faiblesse, perte d\u2019app\u00e9tit. Seul l\u2019espoir de gu\u00e9rison les aide \u00e0 supporter ce calvaire. Cependant, de nombreux patients ne gu\u00e9rissent pas, les premiers traitements n\u2019avaient un taux [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/\" \/>\n<meta property=\"og:site_name\" content=\"biotechlerncenter\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-13T15:49:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/\",\"name\":\"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse - biotechlerncenter\",\"isPartOf\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg\",\"datePublished\":\"2026-03-12T16:26:16+00:00\",\"dateModified\":\"2026-03-13T15:49:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg\",\"contentUrl\":\"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sujets\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"H\u00e9patite: lorsque le foie souffre d\u2019une inflammation\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/hepatite-lorsque-le-foie-souffre-dune-inflammation\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/\",\"name\":\"biotechlerncenter\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse - biotechlerncenter","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/","og_locale":"fr_FR","og_type":"article","og_title":"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse","og_description":"Pendant de nombreuses ann\u00e9es, le traitement standard de l\u2019h\u00e9patite C \u00e9tait constitu\u00e9 d\u2019interf\u00e9ron et de ribavirine. Pour les patients, ce traitement est extr\u00eamement \u00e9prouvant: maux de t\u00eates permanents, fi\u00e8vre, faiblesse, perte d\u2019app\u00e9tit. Seul l\u2019espoir de gu\u00e9rison les aide \u00e0 supporter ce calvaire. Cependant, de nombreux patients ne gu\u00e9rissent pas, les premiers traitements n\u2019avaient un taux [&hellip;]","og_url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/","og_site_name":"biotechlerncenter","article_modified_time":"2026-03-13T15:49:38+00:00","og_image":[{"url":"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/","url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/","name":"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse - biotechlerncenter","isPartOf":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage"},"image":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage"},"thumbnailUrl":"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg","datePublished":"2026-03-12T16:26:16+00:00","dateModified":"2026-03-13T15:49:38+00:00","breadcrumb":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#primaryimage","url":"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg","contentUrl":"https:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/grafik_4_hepatits.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/hepatitis-wenn-sich-die-leber-entzuendet\/5-die-rationierung-von-medikamenten-eine-heikle-entscheidung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Sujets","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/"},{"@type":"ListItem","position":3,"name":"H\u00e9patite: lorsque le foie souffre d\u2019une inflammation","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/hepatite-lorsque-le-foie-souffre-dune-inflammation\/"},{"@type":"ListItem","position":4,"name":"5. Rationnement des m\u00e9dicaments: une d\u00e9cision \u00e9pineuse"}]},{"@type":"WebSite","@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website","url":"https:\/\/biotechlerncenter.interpharma.ch\/","name":"biotechlerncenter","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=568"}],"version-history":[{"count":2,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/568\/revisions"}],"predecessor-version":[{"id":3064,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/568\/revisions\/3064"}],"up":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/548"}],"wp:attachment":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}